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Introduction
Cancer remains among the most unresolved dis-
eases for human being yet. Colorectal cancer (CRC) 
is among the most common malignancies and distin-
guished as a major cause of mortality among human 
beings. It ranked as the fourth cause of cancer-related 
death worldwide and responsible for near 1.4 million 
new cases annually (Arnold et al., 2016).
In the growing list of cancer-related risk factors, viral 
infections have a special place with a lot of unsolved 
issues (Haggar et al., 2009; Jemal et al., 2011; Mahmoud-
vand et al., 2015). Viruses, especially DNA viruses 
such as polyomaviruses (JCV and BKV), herpesviruses 
(Epstein-Barr virus), human papilloma viruses and 
hepatitis B virus are the causative agents of 15–20% of 
human cancers including Burkitt’s lymphoma, naso-
pharyngeal carcinoma, Hodgkin’s lymphoma, cervical 
cancer and hepatocellular carcinoma (Sarvari et al., 
2014; Polz-Gruszka et al., 2015; Schafer et al., 2015). 
Although each virus employs specific mechanisms of 
cancer induction, tumorigenic viruses contain onco-
genes, which promote transformation of the infected 
cells, mostly by functional disruption of regulatory pro-
teins, p53 and pRb (Chen et al., 2014). Recently, a num-
ber of studies suggested that viruses such as human pap-
illomavirus (HPV), BK, JC and EBV may be related to 
the outcome of colorectal cancer (Antonic et al., 2013).
EBV, as a ubiquitous herpesvirus, has a widespread 
distribution among human populations (Moeini et al., 
2015). After primary infection through saliva, it estab-
lishes a persistent and lifelong infection in almost all 
individuals. While the direct role of EBV in the pro-
gression of a number of malignancies, including Burkit 
lymphoma, nasopharyngeal carcinoma and gastric can-
cer has been revealed (Kadivar et al., 2011), its impact 
on colorectal cancer development remains controversial 
(Fiorina et al., 2014). 
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A b s t r a c t
Viruses including Epstein-Barr virus (EBV), JCV and BKV have been reported to be associated with some cancers. The association of these 
viruses with colorectal cancers remains controversial. Our objective was to investigate their infections association with adenocarcinoma and 
adenomatous polyps of the colon. Totally, 210 paraffin-embedded tissue specimens encompassing 70 colorectal adenocarcinoma, 70 colo-
rectal adenomatous and 70 colorectal normal tissues were included. The total DNA was extracted, then qualified samples introduced to 
polymerase chain reaction (PCR). The EBV, JCV and BKV genome sequences were detected using specific primers by 3 different in-house 
PCR assays. Out of 210 subjects, 98 cases were female and the rest were male. The mean age of the participants was 52 ± 1.64 years. EBV 
and JCV DNA was detected just in one (1.42%) out of seventy adenocarcinoma colorectal tissues. All adenomatous polyp and normal colo-
rectal tissues were negative for EBV and JCV DNA sequences. Moreover, all the patients and healthy subjects were negative for BKV DNA 
sequences. The results suggested that EBV and JCV genomes were not detectable in the colorectal tissue of patients with colorectal cancer 
in our population. Hence, BKV might not be necessitated for the development of colorectal cancer. The findings merit more investigations.
K e y  w o r d s: Epstein-Barr virus, adenocarcinoma, colorectal cancer, JCV, BKV, adenomatous
Sarvari J. et al. 174
Polyomaviruses including JCV, and BKV are prev-
alent small and non-enveloped viruses that contain 
a 5Kb circular double-stranded DNA genome (Pinto 
and Dobson 2014). The large or small T antigen (TAg 
or tAg) and agnoprotein of JCV have been implicated 
in blocking of p53 or pRb functions, interaction with 
β-catenin that consequently induces chromosomal 
instability, promoting gene damage and neoplastic 
conversion (Nosho et al., 2009; Collins et al., 2011). 
Moreover, JCV genome sequence as well as T-antigen 
expression have been detected in a broad range of 
brain tumors (Collins et al., 2011; Mou et al., 2012), 
indicating a possible association with its carcinogen-
esis. However, if JCV is attributed to the establishment 
or progression of colorectal carcinoma remained to 
be elucidated well (Rollison et al., 2010; Sinagra et al., 
2014). BKV, another species of polyomaviruses, has also 
been proposed as a tumor virus, whose expression of 
oncoproteins, TAg and tAg transforms and immortal-
izes the rodent and human cells (Abend et al., 2009). As 
the evidence supporting the strong association of BKV 
infection or expression of its proteins with tumor devel-
opment in the case of colorectal cancer is limited, the 
subject needs to be delineated further (Giuliani et al., 
2008; Abend et al., 2009).
Cancer is the third cause of death in Iran. Follow-
ing lung and breast cancers, colorectal cancer is the 
third most common cause of cancer here (Mousavi 
et al., 2009). The incidence rate of colorectal cancer in 
Iran is 5000 new cases annually, which lead a mortality 
rate of 2 per 100,000 cases (Esna-Ashari et al., 2009). 
Although different reports regarding the possible cor-
relation between viral infection and colorectal cancer 
have been published from Iran, studies which inves-
tigated the role of EBV, JCV and BKV in this kind of 
cancer are scanty. Therefore, this study was conducted 
to evaluate the association between EBV, JCV and BKV 
infections and adenocarcinoma/adenomatous colorec-
tal cancer in a population from the southwest of Iran.
Experimental
Materials and Methods
Patients and samples. Two hundred ten paraffin-
embedded biopsy specimens, including 70 adenocar-
cinoma colorectal tissues, 70 adenomatous colorectal 
tissues and 70 normal colorectal tissues were included 
in this study. The samples were collected from Faghihi 
Hospital, a teaching hospital affiliated to Shiraz Uni-
versity of Medical Sciences. The state of cases and rel-
evant tissue samples had been examined by a specialist 
pathologist and the selected ones prepared according 
to the pathology reports (Fig. 1) from early 2012 to late 
2013. The study was approved by the Ethics Commit-
tee of the University and the informed consent was 
obtained from all patients before sampling.
DNA extraction. Paraffin-embedded tissue samples 
were cut and deparaffinized by adding xylene as descri-
bed before (Bakhtiyrizadeh et al., 2017). Briefly, the sam-
ples were vortexed and incubated at room temperature 
and underwent centrifugation at 14.000 RPM for 5 min. 
Then, the supernatants were detached and absolute etha-
nol was added to each tube then incubated for 5 more 
minutes at room temperature. Finally, the tubes under-
went high-speed centrifugation and the supernatants 
were discarded. Both steps were repeated once. In the 
final step, the tubes were incubated at 37°C until the 
ethanol evaporated. The total DNA was then extracted 
using a QIAamp DNA minikit (Qiagen Inc., Düsseldorf, 
Germany) according to the manufacturer’s instructions. 
The extracted DNA was stored at −20°C until use.
Polymerase Chain Reaction (PCR). To confirm the 
quality of the extracted DNA, all the DNA samples were 
primarly subjected to β-globin gene PCR with primers 
PCO3/PCO4 (Table I) and unsuitable negative samples 
were excluded from further experiments (Bakhtiyriza-
deh et al., 2017). The PCR reactions were performed in 
a total volume of 25 μl, containing 1 mM MgCl2, 200 μM 
Fig. 1. Histopathology evaluation of different human colorectal tissues.
A: A photomicrograph of human normal colorectal mucosa. B: A photomicrograph of human colorectal adenomatous C: A photomicrograph of 
human colorectal adenocarcinoma. (H&E×250)
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(each) deoxyribonucleotide triphosphates (dNTPs), 
1 U Taq DNA polymerase (CinnaGene Inc., Iran) and 
1 μM of each specific primers. Specific primers targeting 
LMP-1 for EBV, TAg for BK and JC viruses and regula-
tory regions of BKV were selected from previous studies 
(Nickeleit, Klimkait et al. 2000, Hoshida, Tomita et al. 
2004, Giraud, Ramqvist et al. 2008), as shown in Table I. 
To make sure of the validity of the tests, a set of control 
positive BKV, JCV and EBV DNA samples were also 
provided by other colleagues (Emami et al., 2015) from 
transplant research center, affiliated to Shiraz University 
of Medical Sciences and included in all runs.
The screening PCR tests for β-globin were carried 
out as follows: primary 10 min initial denaturation at 
94°C, 35 cycles of denaturation at 94°C for 45 s, anneal-
ing at 44°C for 45 s, extension at 72°C for 1 min follow-
ing a final extension at 72°C for 10 min. All the positive 
β-globin gene PCR samples were introduced into fur-
ther confirmatory EBV, JCV and BKV PCRs, using spe-
cific primers. PCR program for amplification of LMP-1 
region of EBV was set using HIW1/2 primer pair as 
follows: 10 min initial denaturation at 95°C, 50 cycles 
of denaturation at 95°C for 1 min, annealing at 58°C 
for 1min, extension at 72°C for 90 sec following a final 
extension step at 72°C for 8 min. PCR tests for Large 
T-antigen coding region of JCV was performed by the 
help of PEP-1/2 as follows: 10 min initial denaturation 
at 95°C, 50 cycles of denaturation at 95°C for 1 min, 
annealing at 48°C for 1 min, extension at 72°C 2 min, 
and a final extension at 72°C for 8 min. PCR targeting 
regulatory regions of BKV was performed with BRP-1/2 
primers, as follows: 10 min initial denaturation at 95°C, 
35 cycles of denaturation at 95°C for 1 min, anneal-
ing at 62°C for 1 min, extension at 72°C for 90 sec, and 
final extension at 72°C for 8 min. The PCR products 
were then loaded into 1.5% agarose gel, stained with 1% 
ethidium bromide, and visualized under UV exposure.
Statistical analysis. Data were analyzed using SPSS 
16 (SPSS Inc., Chicago, IL, USA) software. Fisher’s exact 
test was used for data analysis. A P-value below 0.05 was 
considered as statistically significant.
Results
Totally, 217 samples were selected primarily for early 
assessment, and then 210 specimens were included 
based on β-globin gene positive signals in electro-
phoresis. Out of 210 subjects included in this study, 
98 were female and the rest were male. The mean age 
was 52 ± 1.64 SD years and the patients’ age ranged 
between 22 and 87 years. Out of 140 patients of the 
study group, 63 and 77 were female and male, respec-
tively. Out of 70  indi viduals in the control group, 
35 were female and the rest were male. Anatomic loca-
tions of the samples were 89 (42.38%) colon tissue, 
28 (13.33%) rectum tissue, 24 (11.42%) sigmoid tissue, 
and 69 (32.85%) other tissues.
On the bases of grading system, out of 70 colorectal 
adenocarcinoma, 48 well differentiated, 17 moderately 
differentiated, 3 poorly differentiated and 2  invasive 
sample were determined. Also, regarding the stag-
ing system of 70 colorectal adenocarcinoma 8 stage I, 
1 stage II, 18 stage IIA, 1 stage IA, 1 stage IIIA, 1 stage IB, 
1 stage IIB, 12 stage IIIB, 1 stage IIC, 3 stage IIC, 1 stage 
IV and 1 stage IVB were histologically recognized.
Those extracting DNAs that were positive for 
β-globin gene amplification reaction, showed a 110 bp 
band in electrophoresis indicative of the integrity of 
samples for further experiments. All the 210 suitable 
DNA samples were then subjected to EBV, JCV, and 
BKV DNA sequence detection. After electrophoresis 
of PCR results, detection of 129, 265 or 173 bp ampli-
cons on electrophoresis were indicative of EBV, BKV 
and JCV, respectively, as depicted in Fig. 2. From all 
investigated specimens, the EBV and JCV genome was 
identified in only 1 of adenocarcinoma samples. All of 
adenomatous and normal biopsy specimens were nega-
tive for both viruses. Moreover, none of the 140 patients 
and 70 healthy biopsy specimens was positive for BKV 
using specific primer set.
Statistical analysis did not show any significant 
differences in the frequency of EBV, JCV and BKV 
DNA between adenocarcinoma/adenomatous, colorectal 
β-globin
 PCO3 5’-ACACAACTGTGTTCACTAGC-3’ 
110
 PCO4 5’-CAACTTCATCCACGTTCACC-3’ 
JCV
 PEP-1 5’-AGTCTTTAGGGTCTTCTACC-3’ 
173
 PEP-2 5’-GGTGCCAACCTATGGAACAG-3’ 
BKV
 BRP-1 5’-TTGAGAGAAAGGGTGGAGGC-3’ 
265
 BRP-2 5’-GCCAAGATTCCTAGGCTCGC-3’ 
EBV




The sequences and other characteristics of primers.
Target Primers 5’ to 3’ Sequence Product size, bp
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tissue and normal biopsy specimens. The analysis also 
revealed no differences in the frequency of EBV, JCV 
and BKV DNA between adenocarcinoma and normal 
colorectal tissues. Totally, EBV and JCV DNA were 
detected in only adenocarcinoma but not adenoma-
tous or normal biopsy specimens. Regarding the sex of 
the infected subjects, both infected samples were 
female. Although the EBV and JCV DNA were detect-
able only in female patients, the difference was not sta-
tistically significant. Clearly, considering the very low 
frequency of positive samples, there was no significant 
correlation between grade and stages of malignancy 
and virus frequency. The age of the EBV and JCV posi-
tive patients were 56 and 58 years, respectively; which 
was a little older than the mean age of the participants. 
The anatomic location of EBV and JCV positive samples 
was colon tissue. 
Discussion
Among all the human tumors, CRC with more than 
1 million new affected cases annually is categorized as 
the third most common cancer, worldwide (Parkin, 
Bray et al. 2005). In a similar pattern, in Iran, CRC is 
recognized as the third most common type of cancers 
following lung and breast cancers (Kolahdoozan et al., 
2010). While the role of viruses such as EBV, JCV, 
and BKV in tumor development has been suggested 
(Hollingworth et al., 2015), their true impact on the 
development of CRC remained to be determined. 
Herein, we conducted a study to investigate EBV, BKV 
and JCV virus presence in colorectal tumor tissue, 
including 70  adenocarcinoma and 70 adenomatous 
samples in comparison to 70 normal colorectal tissues. 
In our study, EBV DNA was detected in only 1 out of 
70 (1.4%) adenocarcinoma colorectal tissues while the 
rest were negative. Regarding the very low frequency, 
statistical analysis did not show a significant differ-
ence among groups. In parallel with our result, Mili-
tello et al. reported a very low frequency of EBV DNA 
in 72 cancerous and cancer-adjacent mucous samples 
(4.2% versus 1.4% ) (Militello et al., 2009). Boguszakova 
et al. also failed to detect EBV DNA in the biopsy spec-
imens from adenocarcinoma/adenomatous colorectal 
tissues (Boguszakova et al., 1988). Similarly, Cho et al. 
reported no sign of EBER gene expression in colorectal 
tumor specimens, from 274 Korean patients. (Cho et al., 
2001). Differently, high frequency of EBV genome was 
recognized in a similar frequency in both cancerous 
and normal colorectal samples. In Italy, Fiorina et al. 
reported the presence of EBV DNA in 52% of CRC tis-
sues without including a negative control group. They 
also showed that most of EBV infections are latent in 
infiltrating lymphocyte as just a small part of the cells 
was positive for BZLF-1, a marker of lytic replication 
(Fiorina et al., 2014). In Iran, reports demonstrated the 
high but similar frequency of EBV at tumor samples, 
polyp specimens and non-malignant control group 
(Mehrabani Khasraghi et al., 2015; Tafvizi et al., 2015). 
These data are supportive for the absence of a signifi-
cant correlation between EBV and CRC development. 
In opposite, Liu et al. in China showed that EBV 
DNA is detectable in 21% (26/136) of adenocarcinoma/
adenomatous specimens and introduced EBV as a car-
cinogenic agent in colorectal cancer, a finding that was 
achieved by performing 3 different detection meth-
ods (Liu et al., 2003). In another study, EBV DNA was 
detected as a prevalent pathogen in 19% of 186 cases 
of sporadic colorectal cancer by using PCR assay albeit 
Fig. 2. Results of gel electrophoresis.
(A) PCR analysis of DNA samples using type-specific primers for EBV. M: 100 bp Marker, C+: Control positive, C–: Negative control, 1 (a positive 
sample), 2 and 3: negative samples. (B) PCR analysis of DNA samples using type-specific primers for BKV. M: 100 bp Marker, C+: Control positive, 
C–: Negative control, 1 and 2 and negative samples. (C) PCR analysis of DNA samples using type-specific primers for JCV. M: 100 bp DNA Marker; 
C+: positive control; C–: Negative control; 1(a positive sample), 2 and 3: Negative samples.
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no normal control specimens were included (Karpinski 
et al., 2011). Ruschoff et al. found EBV genome in 15% 
of cases with colorectal malignancy by using PCR, and 
then suggested its association with colorectal tumor 
(Ruschoff et al., 1997). Hence, from pioneer studies 
EBV has been suggested to be a colorectal cancer asso-
ciated virus (Kim et al., 1998; Grinstein et al., 2002). 
From all the findings, a clear controversy arose 
regarding the direct role of EBV in CRC development. 
Whereas reports suggesting the tumorigenic role of 
EBV are abundant, studies acclaiming no association 
with CRC are limited, as ours one. This type of contro-
versy may lie in the differences of genetic background, 
geographical differences, possible co-factors effects as 
well as sample size. Otherwise, contamination during 
sample preparation as well as differences in the detec-
tion limit of the methods may inevitably explain these 
diversities (Mehrabani Khasraghi et al., 2015). Sepa-
rately of all the subjects, in some reports, the misleading 
achievements may be obtained due to tumor-infiltrat-
ing lymphocytes (TILs) and the site of sampling which 
may harbor latent viruses (Karpinski et al., 2011).
In the case of JCV, only one cancerous sample was 
diagnosed to be infected with the virus. In agreement 
with our results, in two other large studies, the fre-
quency of JCV infection was reported 1% and 0% of 
the investigated CRC tissues (Losa, Fernandez-Soria 
et al., 2003; Newcomb et al., 2004). Also, in studies from 
Italy, none of 72 and 71 cancerous and paired adjacent 
samples were positive for JCV (Giuliani et al., 2008, 
Militello et al., 2009). Moreover, Lundstig et al. showed 
no increased risk for colorectal cancer among subjects 
seropositive for JCV in a large prospective follow up 
in healthy Norwegian male subjects (Lundstig et al., 
2007). However, others reported the presence of JCV 
DNA with different frequencies in colon cancer speci-
mens in different areas (Laghi et al., 1999; Enam et al. 
2002; Mou et al., 2012). The first report considering the 
implication of JCV in CRC establishment was presented 
by Laghi et al., following an investigation on 24 speci-
mens with 96% positive signal for virus DNA (Laghi 
et al., 1999). In recent efforts, JCV infection in CRC 
tissue has been detected more prevalently than normal 
colon sample by using a molecular assay (Mou et al., 
2012; Ksiaa et al., 2015) Also in Portugal, Coelho et al. 
reported the rate of 40% and 90% JCV DNA in normal 
mucosa from the control and patient subjects, respec-
tively (Coelho et al., 2013). They suggested a selective 
advantage for expanding virus harboring cells toward 
colorectal tumor progression. Karpinski et al. reported 
9% frequency of JCV infection among 186 tissues from 
colorectal cancer in Poland (Karpinski et al., 2011). 
The possible reason behind the variation in findings is 
including differences in the detection limit of the assays 
between laboratories, patient genetic background, and 
possible contamination of specimens (Rollison et al., 
2010). As a low copy-replicating virus, JCV viral load in 
the colorectal tissue is expected to be under the detec-
tion limit of some molecular methods, reasons behind 
the diversity of immunohistochemistry, PCR, and real-
time PCR assays as described before (Laghi et al., 1999). 
As mentioned for EBV, age, gender, area of study as well 
as the lifestyle could also contribute to different rates of 
JCV infection. Besides all, the site of sampling may also 
reflect different types of findings due to the diversity of 
resident cells.
In the case of BKV, none of the samples were posi-
tive for BKV genome. Although BKV and JCV are in 
the same family, clues regarding the role of BKV in 
tumor induction is not as much as for JCV. In agree-
ment with this, in a study from Italy, no evidence for 
the BKV contribution in colorectal cancer develop-
ment was reported (Militello et al., 2009). Moreover, 
Lundstig et al. showed no increased risk for colorec-
tal cancer among subjects seropositive for the BKV in 
a large prospective study of Norwegian men (Lundstig 
et al., 2007). Others showed the presence of BKV DNA 
sequence in 9% (6/66) of Italian patients with colorec-
tal cancer (Giuliani et al., 2008). Regarding the above 
results, BKV infection might not be involved in the 
pathogenesis of colorectal cancer as none of the afore-
mentioned studies reported an association with colo-
rectal cancer development.
In our study, the age of only one EBV positive patient 
was 56 years that was a little older than the participants’ 
mean age. In another report from Iran, Mehrabani et al. 
reported the highest prevalence of EBV in patients with 
colorectal cancer aged 35–55 years and over 55 years 
(Mehrabani Khasraghi et al., 2015). Furthermore, the 
prevalence of EBV in men and women was determined 
53.3% and 25%, respectively (Mehrabani Khasraghi 
et al., 2015). In our study, the anatomic locations of 
EBV and JCV positive sample were from the colon 
tissue. Mehrabani Khasraghi et al. reported the high-
est prevalence rate of the virus in the proximal colon 
(Mehrabani Khasraghi et al., 2015). In the present study, 
EBV and JCV positive samples were from females’ sub-
jects. Although the frequency of EBV positive cases was 
higher in the colorectal cancer tissues from females 
than males, the difference was not statistically signifi-
cant (p = 0.41). Collectively, statistical analysis showed 
no significant association between the frequency of 
EBV and age, gender and anatomic location in patients 
with colorectal cancer in our and others’ studies.
While the results may be supported by some other 
aforesaid studies, limitation, including small malignant 
sample size, duration of sampling, employment of an 
endpoint PCR assay and a paraffin-embedded moiety 
of samples should be considered for future study as they 
all restrict the detection potency and final conclusion. 
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In conclusion, the results suggested that EBV and 
JCV infection is not common in patients with colorectal 
cancer in our population. Moreover, BKV might not 
be involved in the pathogenesis of colorectal cancer. 
The study collectively indicated a very low frequency 
of BKV, EBV and JCV in the colorectal cancer tissue 
among our population; however, the findings merit 
more investigations on a large number of cases.
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